TARA
Protara Therapeutics Inc
3.40$
-5.4%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 88.0% | 87.0% | 85.0% | 90.7% | 90.4% | 94.9% | 75.1% | 79.7% | 93.8% | 76.1% | 72.9% | 83.0% | |
| 38.2% | 50.1% | 76.7% | 88.1% | 55.0% | 89.7% | 54.3% | 20.1% | 8.7% | 23.7% | 7.7% | 9.7% | |
| 83.7% | 83.1% | 81.1% | 88.1% | 86.6% | 93.8% | 73.8% | 77.9% | 91.7% | 74.3% | 70.8% | 9.7% | |
| 0.3% | 0.3% | 0.0% | – | – | – | 0.2% | 0.6% | 0.7% | 0.6% | 0.8% | – | |
| -0.3% | – | – | – | – | – | – | – | – | – | – | – | |
| – | 3.4% | 3.9% | 2.5% | 2.7% | 1.8% | 1.8% | 1.9% | 2.1% | 1.4% | 3.1% | 3.3% | |
| 13.0% | 13.5% | 14.3% | 9.4% | 13.1% | 7.9% | 6.0% | 8.0% | 8.5% | 6.2% | 5.6% | 8.4% | |
| 7.7% | 7.8% | 8.1% | 5.6% | 9.2% | 6.0% | 4.2% | 6.2% | 6.9% | 5.2% | 4.6% | 7.6% | |
| 1.1% | 1.2% | 1.5% | 1.0% | 1.1% | 0.6% | 0.7% | 0.8% | 0.8% | 0.6% | 0.7% | 0.7% | |
| 2.8% | 3.1% | 1.4% | 1.4% | 2.4% | 2.4% | 1.4% | 3.4% | 3.1% | 1.7% | 2.1% | 2.6% | |
| 87.0% | 86.5% | 85.7% | 90.6% | 86.9% | 92.1% | 94.0% | 92.0% | 91.5% | 93.8% | 94.4% | 91.6% | |
| -215.0% | -253.8% | -310.4% | -217.4% | -246.8% | -135.0% | -152.4% | -173.2% | -197.1% | -144.4% | -166.8% | -194.1% | |
| 12.8% | 14.4% | 16.8% | 20.9% | 23.7% | 14.6% | 24.2% | 26.9% | 29.2% | 22.0% | 30.0% | 34.6% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.